# Akebia Therapeutics, Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:bad017fc-48c8-414b-909d-59a159d476d0 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/akebia-therapeutics-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 27 | | Claims under review | 1 | | Evidence records | 8 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-16T13:52:54.339891+00:00 | | Last reviewed | 2026-10-16T13:52:54.339891+00:00 | ## Identity - Legal name: Akebia Therapeutics, Inc. - Display name: Akebia Therapeutics, Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-17T04:41:22.976047+00:00 | | Completeness | 0.409 | | Record Quality | 0.843 | | Directors | 8 | | Committees | 7 | | Governance events | 22 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Adrian Adams: Director. Status: current. Independent: true. Since: 2018-01-01. Committees: Compensation (member). claim_id=alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:leadership_role:5 - Cynthia Smith: Director. Status: current. Independent: true. Since: 2018-01-01. Committees: Compensation (chair); Compensation · Chair (member). claim_id=alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:leadership_role:6 - John P. Butler: Director. Status: current. Independent: false. Since: 2013-01-01. claim_id=alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:leadership_role:7 - LeAnne M. Zumwalt: Director. Status: current. Independent: true. Since: 2021-01-01. Committees: Audit (member); Audit; Nominating and Governance (member); Nominating and Governance (member). claim_id=alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:leadership_role:8 - Michael Rogers: Director. Status: current. Independent: true. Since: 2018-01-01. Committees: Audit (chair); Audit · Chair (member). claim_id=alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:leadership_role:9 - Myles Wolf, M.D., M.M.Sc.: Director. Status: current. Independent: true. Since: 2020-01-01. claim_id=alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:leadership_role:10 - Ronald E. Frieson: Director. Status: current. Independent: true. Since: 2021-01-01. Committees: Audit (member); Audit; Nominating and Governance · Chair (member); Nominating and Governance (chair). claim_id=alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:leadership_role:11 - Steven C. Gilman, Ph.D.: Director. Status: current. Independent: true. Since: 2018-01-01. claim_id=alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:leadership_role:12 ## Committees - Audit (audit). Chair: Michael Rogers. Members: Michael Rogers (chair, current); LeAnne M. Zumwalt (member, current); Ronald E. Frieson (member, current). committee_id=alpha:committee:akebia-therapeutics-inc:audit - Audit · Chair (audit). Chair: NOT_PUBLISHED. Members: Michael Rogers (member, current). committee_id=alpha:committee:akebia-therapeutics-inc:audit-chair - Audit; Nominating and Governance (audit). Chair: NOT_PUBLISHED. Members: LeAnne M. Zumwalt (member, current). committee_id=alpha:committee:akebia-therapeutics-inc:audit-nominating-and-governance - Audit; Nominating and Governance · Chair (audit). Chair: NOT_PUBLISHED. Members: Ronald E. Frieson (member, current). committee_id=alpha:committee:akebia-therapeutics-inc:audit-nominating-and-governance-chair - Compensation (compensation). Chair: Cynthia Smith. Members: Cynthia Smith (chair, current); Adrian Adams (member, current). committee_id=alpha:committee:akebia-therapeutics-inc:compensation - Compensation · Chair (compensation). Chair: NOT_PUBLISHED. Members: Cynthia Smith (member, current). committee_id=alpha:committee:akebia-therapeutics-inc:compensation-chair - Nominating and Governance (nominating_governance). Chair: Ronald E. Frieson. Members: Ronald E. Frieson (chair, current); LeAnne M. Zumwalt (member, current). committee_id=alpha:committee:akebia-therapeutics-inc:nominating-and-governance ## Executive leadership - Carolyn M. Rucci: Senior Vice President, Chief Legal Officer and Secretary [GC]. Status: current. claim_id=alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:leadership_role:13 - Erik J. Ostrowski: Senior Vice President, Chief Financial Officer, Chief Business Officer and Treasurer [CFO]. Status: current. claim_id=alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:leadership_role:14 - John P. Butler: President, Chief Executive Officer and Director [CEO]. Status: current. claim_id=alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:leadership_role:15 - Nicholas P. Grund: Senior Vice President, Chief Commercial Officer. Status: current. claim_id=alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:leadership_role:16 - Steven K. Burke: Senior Vice President, Chief Research Development and Medical Officer. Status: current. claim_id=alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:leadership_role:17 ## Governance events - GC_CHANGED: Carolyn M. Rucci executive of Akebia Therapeutics, Inc., effective 2026-04-28. Effective: 2026-04-28. Detected: 2026-10-16T13:52:54.339891+00:00. event_id=alpha:event:transition:19ytrsf4e1sxl - CFO_CHANGED: Erik J. Ostrowski executive of Akebia Therapeutics, Inc., effective 2026-04-28. Effective: 2026-04-28. Detected: 2026-10-16T13:52:54.339891+00:00. event_id=alpha:event:transition:144qgiz16muoq3 - CEO_CHANGED: John P. Butler executive of Akebia Therapeutics, Inc., effective 2026-04-28. Effective: 2026-04-28. Detected: 2026-10-16T13:52:54.339891+00:00. event_id=alpha:event:transition:1cswclmz7y4x0 - EXECUTIVE_APPOINTED: Nicholas P. Grund executive of Akebia Therapeutics, Inc., effective 2026-04-28. Effective: 2026-04-28. Detected: 2026-10-16T13:52:54.339891+00:00. event_id=alpha:event:transition:6ahtiys7ehwg - EXECUTIVE_APPOINTED: Steven K. Burke executive of Akebia Therapeutics, Inc., effective 2026-04-28. Effective: 2026-04-28. Detected: 2026-10-16T13:52:54.339891+00:00. event_id=alpha:event:transition:2agq3d1npkmbl - DIRECTOR_APPOINTED: LeAnne M. Zumwalt seat on Akebia Therapeutics, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T13:52:54.339891+00:00. event_id=alpha:event:transition:7wipeegcsuiu - DIRECTOR_APPOINTED: Ronald E. Frieson seat on Akebia Therapeutics, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T13:52:54.339891+00:00. event_id=alpha:event:transition:19yfak2yyyrti - COMMITTEE_CREATED: Audit; Nominating and Governance committee of Akebia Therapeutics, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T13:52:54.339891+00:00. event_id=alpha:event:transition:wxvwlcebl5re - COMMITTEE_MEMBER_ADDED: LeAnne M. Zumwalt member of Audit; Nominating and Governance, effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T13:52:54.339891+00:00. event_id=alpha:event:transition:1ylhb6cr0e6ja - COMMITTEE_CREATED: Audit; Nominating and Governance · Chair committee of Akebia Therapeutics, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T13:52:54.339891+00:00. event_id=alpha:event:transition:1sbkjz8u42lqy - COMMITTEE_MEMBER_ADDED: Ronald E. Frieson member of Audit; Nominating and Governance · Chair, effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T13:52:54.339891+00:00. event_id=alpha:event:transition:1f8750y1oow25y - DIRECTOR_APPOINTED: Myles Wolf, M.D., M.M.Sc. seat on Akebia Therapeutics, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-16T13:52:54.339891+00:00. event_id=alpha:event:transition:14l5mfoytjdr6 - DIRECTOR_APPOINTED: Adrian Adams seat on Akebia Therapeutics, Inc., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-16T13:52:54.339891+00:00. event_id=alpha:event:transition:14660d1xow46p - DIRECTOR_APPOINTED: Cynthia Smith seat on Akebia Therapeutics, Inc., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-16T13:52:54.339891+00:00. event_id=alpha:event:transition:nk7qcz7y3hq - DIRECTOR_APPOINTED: Michael Rogers seat on Akebia Therapeutics, Inc., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-16T13:52:54.339891+00:00. event_id=alpha:event:transition:6j6vqph30g5x - DIRECTOR_APPOINTED: Steven C. Gilman, Ph.D. seat on Akebia Therapeutics, Inc., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-16T13:52:54.339891+00:00. event_id=alpha:event:transition:1sc14efjv9xkn - COMMITTEE_CREATED: Audit · Chair committee of Akebia Therapeutics, Inc., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-16T13:52:54.339891+00:00. event_id=alpha:event:transition:7hs7elzh2wct - COMMITTEE_MEMBER_ADDED: Michael Rogers member of Audit · Chair, effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-16T13:52:54.339891+00:00. event_id=alpha:event:transition:drfu9rhlk2ff - COMMITTEE_MEMBER_ADDED: Adrian Adams member of Compensation, effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-16T13:52:54.339891+00:00. event_id=alpha:event:transition:1c8ouufu6a8aj - COMMITTEE_CREATED: Compensation · Chair committee of Akebia Therapeutics, Inc., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-16T13:52:54.339891+00:00. event_id=alpha:event:transition:1ids6di1a109ky - COMMITTEE_MEMBER_ADDED: Cynthia Smith member of Compensation · Chair, effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-16T13:52:54.339891+00:00. event_id=alpha:event:transition:1umuubb1938upt - DIRECTOR_APPOINTED: John P. Butler seat on Akebia Therapeutics, Inc., effective 2013-01-01. Effective: 2013-01-01. Detected: 2026-10-16T13:52:54.339891+00:00. event_id=alpha:event:transition:5spyhg1a01hqg ## Scoped resources - `alpha://company/akebia-therapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/akebia-therapeutics-inc?format=record - `alpha://company/akebia-therapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/akebia-therapeutics-inc?format=record§ion=identity - `alpha://company/akebia-therapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/akebia-therapeutics-inc?format=record§ion=corporate-structure - `alpha://company/akebia-therapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/akebia-therapeutics-inc?format=record§ion=board - `alpha://company/akebia-therapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/akebia-therapeutics-inc?format=record§ion=committees - `alpha://company/akebia-therapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/akebia-therapeutics-inc?format=record§ion=leadership - `alpha://company/akebia-therapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/akebia-therapeutics-inc?format=record§ion=ownership - `alpha://company/akebia-therapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/akebia-therapeutics-inc?format=record§ion=financials - `alpha://company/akebia-therapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/akebia-therapeutics-inc?format=record§ion=capital-structure - `alpha://company/akebia-therapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/akebia-therapeutics-inc?format=record§ion=compensation - `alpha://company/akebia-therapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/akebia-therapeutics-inc?format=record§ion=governance - `alpha://company/akebia-therapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/akebia-therapeutics-inc?format=record§ion=shareholder-governance - `alpha://company/akebia-therapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/akebia-therapeutics-inc?format=record§ion=audit - `alpha://company/akebia-therapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/akebia-therapeutics-inc?format=record§ion=legal - `alpha://company/akebia-therapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/akebia-therapeutics-inc?format=record§ion=risk - `alpha://company/akebia-therapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/akebia-therapeutics-inc?format=record§ion=cyber - `alpha://company/akebia-therapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/akebia-therapeutics-inc?format=record§ion=ai-governance - `alpha://company/akebia-therapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/akebia-therapeutics-inc?format=record§ion=agents - `alpha://company/akebia-therapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/akebia-therapeutics-inc?format=record§ion=ecosystem - `alpha://company/akebia-therapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/akebia-therapeutics-inc?format=record§ion=events - `alpha://company/akebia-therapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/akebia-therapeutics-inc?format=record§ion=relationships - `alpha://company/akebia-therapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/akebia-therapeutics-inc?format=record§ion=assessments - `alpha://company/akebia-therapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/akebia-therapeutics-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:committee_appointment:19: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:michael-rogers","name":"Michael Rogers"},"source_id":"board_seats"}` - Claim alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:committee_appointment:20: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:leanne-m-zumwalt","name":"LeAnne M. Zumwalt"},"source_id":"board_seats"}` - Claim alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:committee_appointment:21: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:ronald-e-frieson","name":"Ronald E. Frieson"},"source_id":"board_seats"}` - Claim alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:committee_appointment:23: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:cynthia-smith","name":"Cynthia Smith"},"source_id":"board_seats"}` - Claim alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:committee_appointment:24: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:adrian-adams","name":"Adrian Adams"},"source_id":"board_seats"}` - Claim alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:committee_appointment:26: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:ronald-e-frieson","name":"Ronald E. Frieson"},"source_id":"board_seats"}` - Claim alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:committee_appointment:27: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:leanne-m-zumwalt","name":"LeAnne M. Zumwalt"},"source_id":"board_seats"}` ## Leadership - Adrian Adams: Director, Compensation. Claim: alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:leadership_role:5. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9377fc911c4ee4f4277341059f915d23a8392e952db25de5330d8a73afb329d9. - Cynthia Smith: Director, Compensation · Chair. Claim: alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:leadership_role:6. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9377fc911c4ee4f4277341059f915d23a8392e952db25de5330d8a73afb329d9. - John P. Butler: Director. Claim: alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:leadership_role:7. Valid from: 2013-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9377fc911c4ee4f4277341059f915d23a8392e952db25de5330d8a73afb329d9. - LeAnne M. Zumwalt: Director, Audit; Nominating and Governance. Claim: alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:leadership_role:8. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9377fc911c4ee4f4277341059f915d23a8392e952db25de5330d8a73afb329d9. - Michael Rogers: Director, Audit · Chair. Claim: alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:leadership_role:9. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9377fc911c4ee4f4277341059f915d23a8392e952db25de5330d8a73afb329d9. - Myles Wolf, M.D., M.M.Sc.: Director. Claim: alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:leadership_role:10. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9377fc911c4ee4f4277341059f915d23a8392e952db25de5330d8a73afb329d9. - Ronald E. Frieson: Director, Audit; Nominating and Governance · Chair. Claim: alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:leadership_role:11. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9377fc911c4ee4f4277341059f915d23a8392e952db25de5330d8a73afb329d9. - Steven C. Gilman, Ph.D.: Director. Claim: alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:leadership_role:12. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9377fc911c4ee4f4277341059f915d23a8392e952db25de5330d8a73afb329d9. - Carolyn M. Rucci: Senior Vice President, Chief Legal Officer and Secretary. Claim: alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:leadership_role:13. Valid from: 2026-04-28. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:63f6fa7b27e8db43e9ff20758f00ebea297253e6c89ad4b4b6eb02e90d6a85da. - Erik J. Ostrowski: Senior Vice President, Chief Financial Officer, Chief Business Officer and Treasurer. Claim: alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:leadership_role:14. Valid from: 2026-04-28. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:946acee5d083e6d383273f64f7250b57cc2b75080e0b922de0d49cdb138d872d. - John P. Butler: President, Chief Executive Officer and Director. Claim: alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:leadership_role:15. Valid from: 2026-04-28. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ff80bae57d6bc02ca80e60bc6ae7b1f390d5c90493f6026c74b4019520e5587a. - Nicholas P. Grund: Senior Vice President, Chief Commercial Officer. Claim: alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:leadership_role:16. Valid from: 2026-04-28. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:69d555864cf0de64d2580883789826f0f983fb993e56b5ac7ab863a8e2bf04b0. - Steven K. Burke: Senior Vice President, Chief Research Development and Medical Officer. Claim: alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:leadership_role:17. Valid from: 2026-04-28. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a36a08428bd41c3a3ce3d486eaf0e636b9da777b3d6c3dd3d12ac08bd648ffc1. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair Michael Rogers; Members Michael Rogers (Chair); LeAnne M. Zumwalt; Ronald E. Frieson. Claim: alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:committee_record:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:86261273562f67a01dba081b1ef5e65d436cae1d10d74d002b2970a6c40c68c2. - Compensation: Chair Cynthia Smith; Members Cynthia Smith (Chair); Adrian Adams. Claim: alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:committee_record:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:86261273562f67a01dba081b1ef5e65d436cae1d10d74d002b2970a6c40c68c2. - Nominating and Governance: Chair Ronald E. Frieson; Members Ronald E. Frieson (Chair); LeAnne M. Zumwalt. Claim: alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:committee_record:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:86261273562f67a01dba081b1ef5e65d436cae1d10d74d002b2970a6c40c68c2. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Akebia Therapeutics, Inc.. Claim: alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:4bd02b8173fed9431d8bd868c2848b390b4605c65327c479d9916da26a0c5b83. ## Entity Status - Public listing published. Claim: alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:4bd02b8173fed9431d8bd868c2848b390b4605c65327c479d9916da26a0c5b83. ## Published Fact - US. Claim: alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:4bd02b8173fed9431d8bd868c2848b390b4605c65327c479d9916da26a0c5b83. ## Committee Appointment - Michael Rogers: chair, Audit. Claim: alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:committee_appointment:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:86261273562f67a01dba081b1ef5e65d436cae1d10d74d002b2970a6c40c68c2. - LeAnne M. Zumwalt: member, Audit. Claim: alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:committee_appointment:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:86261273562f67a01dba081b1ef5e65d436cae1d10d74d002b2970a6c40c68c2. - Ronald E. Frieson: member, Audit. Claim: alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:committee_appointment:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:86261273562f67a01dba081b1ef5e65d436cae1d10d74d002b2970a6c40c68c2. - Cynthia Smith: chair, Compensation. Claim: alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:committee_appointment:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:86261273562f67a01dba081b1ef5e65d436cae1d10d74d002b2970a6c40c68c2. - Adrian Adams: member, Compensation. Claim: alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:committee_appointment:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:86261273562f67a01dba081b1ef5e65d436cae1d10d74d002b2970a6c40c68c2. - Ronald E. Frieson: chair, Nominating and Governance. Claim: alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:committee_appointment:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:86261273562f67a01dba081b1ef5e65d436cae1d10d74d002b2970a6c40c68c2. - LeAnne M. Zumwalt: member, Nominating and Governance. Claim: alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:committee_appointment:27. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:86261273562f67a01dba081b1ef5e65d436cae1d10d74d002b2970a6c40c68c2. ## Security Listing - AKBA (NASDAQ). Claim: alpha:claim:company:bad017fc-48c8-414b-909d-59a159d476d0:security_listing:28. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:4bd02b8173fed9431d8bd868c2848b390b4605c65327c479d9916da26a0c5b83. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:4bd02b8173fed9431d8bd868c2848b390b4605c65327c479d9916da26a0c5b83: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/akebia-therapeutics-inc). - alpha:projection-evidence:document:9377fc911c4ee4f4277341059f915d23a8392e952db25de5330d8a73afb329d9: [Akebia Therapeutics, Inc. DEF 14A 2025-04-29](https://www.sec.gov/Archives/edgar/data/1517022/000151702225000023/akba-20250429.htm). - alpha:projection-evidence:document:63f6fa7b27e8db43e9ff20758f00ebea297253e6c89ad4b4b6eb02e90d6a85da: [AKBA DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1517022/000151702226000034/akba-20260428.htm). - alpha:projection-evidence:document:946acee5d083e6d383273f64f7250b57cc2b75080e0b922de0d49cdb138d872d: [AKBA DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1517022/000151702226000034/akba-20260428.htm). - alpha:projection-evidence:document:ff80bae57d6bc02ca80e60bc6ae7b1f390d5c90493f6026c74b4019520e5587a: [AKBA DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1517022/000151702226000034/akba-20260428.htm). - alpha:projection-evidence:document:69d555864cf0de64d2580883789826f0f983fb993e56b5ac7ab863a8e2bf04b0: [AKBA DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1517022/000151702226000034/akba-20260428.htm). - alpha:projection-evidence:document:a36a08428bd41c3a3ce3d486eaf0e636b9da777b3d6c3dd3d12ac08bd648ffc1: [AKBA DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1517022/000151702226000034/akba-20260428.htm). - alpha:projection-evidence:86261273562f67a01dba081b1ef5e65d436cae1d10d74d002b2970a6c40c68c2: [Audit](https://www.sec.gov/Archives/edgar/data/1517022/000151702225000023/akba-20250429.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/akebia-therapeutics-inc) - [Public Markdown](https://registry.alpha.ac/companies/akebia-therapeutics-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/akebia-therapeutics-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/akebia-therapeutics-inc?format=jsonld) - MCP resource: `alpha://companies/akebia-therapeutics-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-17T04:41:22.781987+00:00; recorded 2026-10-17T04:41:22.781987+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.